Unisys Corporation New (UIS)

On our desk, the Q2 revenue beat of $473.5 million against consensus was a pleasant surprise, driven primarily by strong performance in Technology Solutions and Services. However, looking at the valuation, we cannot ignore the deep net loss expansion to $95.3 million. The $47.2 million goodwill impairment in Digital Workplace Solutions signals structural adjustments that market participants need to weigh carefully against the 57% surge in New Business TCV.

Analyzing the balance sheet metrics as of June 30, 2026, cash and equivalents sit at $324.3 million against total debt of $733.5 million, paired with a stockholders' deficit of $367.4 million. Furthermore, interest expenses of $18.3 million tied to the 10.625% senior secured notes continue to drag on profitability. We are maintaining a cautious stance on leverage risk despite management reaffirming full-year guidance.

Hedging with Q4 put spreads on UIS right now seems prudent given the volatility introduced by the large goodwill impairment and the wider operating loss of $32.9 million. While TSandS gross profit margins improved by 170 basis points to 19.3% due to labor cost savings and delivery improvements, total gross margin dropped to 24.8%. The risk-reward skew warrants strict stop-loss protocols.

From a technical and operational protocol standpoint, the discrepancy between reported headline numbers and operational delivery lies in the uneven timing of ClearPath software license renewals. ClearPath revenue declined by 20.4% to $69.7 million in Q2. Management has guided that full-year visibility assumes ClearPath revenue hitting approximately $425 million, which puts massive execution pressure on the second half of the year.

From a macro and market sentiment angle, the 57% increase in New Business TCV up to $192 million shows that Unisys is capturing strong interest in AI-related services, project work, and field services. Even though adjusted EPS missed the Zacks Consensus Estimate with an adjusted loss of 8 cents per share, the strong top-line beat of $20 million above prior guidance has kept long-only desks engaged for a potential second-half recovery.